2022 FDLI Annual Conference
June 15, 2022

On June 15, Axinn partner Chad Landmon participated in the panel, “The Future of Skinny Labeling and Its Impact on Generics and Biosimilars” at the 2022 FDLI Annual Conference.

Founded in 1949, the Food and Drug Law Institute (FDLI) is a nonprofit membership organization that offers education, training, publications, and professional engagement opportunities in the field of food and drug law.

Click here for more information. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.